图片来源:摄图网
近日,港股上市公司德琪医药发布公告称,与翰森制药达成独家合作协议,由翰森制药负责塞利尼索在中国大陆的商业化, 德琪医药将获最高2亿元首付款及最高5.35亿元里程碑付款。
据了解,塞利尼索是德琪医药首个上市商业化产品,从Karyopharm引进,...查看全文
$Karyopharm(KPTI)$ 内部交易: 2019-09-16,总裁 & CSO,Shacham Sharon ,卖出,10000普通股, $12.00
$Karyopharm(KPTI)$ 内部交易: 2019-09-16,总裁 & CSO,Shacham Sharon ,期权,10000普通股, $4.75
$Karyopharm(KPTI)$ 内部交易: 2019-09-16,CEO,Kauffman Michael ,卖出,10000普通股, $12.00
$Karyopharm(KPTI)$ 内部交易: 2019-09-16,CEO,Kauffman Michael ,期权,10000普通股, $4.75
$Karyopharm(KPTI)$ 8-K - Current report Filed: 2019-09-16 AccNo: 0001193125-19-245346 Size: 204 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Karyopharm(KPTI)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-07 AccNo: 0001193125-19-215344 Size: 8 MB 网页链接
$Karyopharm(KPTI)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2019-08-07 AccNo: 0001193125-19-215473 Size: 101 KB 网页链接
$Karyopharm(KPTI)$ 8-K - Current report Filed: 2019-08-06 AccNo: 0001193125-19-213497 Size: 120 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Karyopharm(KPTI)$ 8-K - Current report Filed: 2019-08-06 AccNo: 0001193125-19-214061 Size: 76 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Financial St...
$Karyopharm(KPTI)$ 美东时间 2019-08-06 盘前 披露财报,预期EPS -0.97 网页链接